摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one | 1204484-56-9

中文名称
——
中文别名
——
英文名称
(1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
英文别名
(1R,5R,6S)-5-[tert-butyl(dimethyl)silyl]oxy-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
(1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one化学式
CAS
1204484-56-9
化学式
C11H21NO3Si
mdl
——
分子量
243.378
InChiKey
ISGVBZVIARRSCC-IWSPIJDZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.27
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    50.9
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 、 sodium cyanamide 在 作用下, 以 二甲基亚砜 为溶剂, 反应 24.0h, 以65%的产率得到(3aS,7R,7aS)-2-amino-7-((tert-butyldimethylsilyl)oxy)-5,6,7,7a-tetrahydrooxazolo[4,5-c]pyridin-4(3aH)-one
    参考文献:
    名称:
    来自氰胺诱导的环氧-δ-内酰胺重排的具有天然产物样复杂性的 1,3-二氮杂
    摘要:
    开发了一种合成程序,用于构建 RNA 导向的配体库,以构建具有天然产物样复杂性的 1,3-二氮杂环支架。设计了一种分子构建块,它结合了 RNA 结合天然产物的特征,包括围绕刚性非平面支架的高密度氢键供体和受体,具有直接的全合成可及性,允许对化学空间进行广泛的控制。1,3-二氮杂环支架的合成是通过前所未有的氰胺诱导的环氧-δ-内酰胺重排实现的。
    DOI:
    10.1021/ol9026914
  • 作为产物:
    描述:
    (1R,6R)-5-hydroxy-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 、 叔丁基二甲基氯硅烷咪唑 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.08h, 以56%的产率得到(1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
    参考文献:
    名称:
    来自氰胺诱导的环氧-δ-内酰胺重排的具有天然产物样复杂性的 1,3-二氮杂
    摘要:
    开发了一种合成程序,用于构建 RNA 导向的配体库,以构建具有天然产物样复杂性的 1,3-二氮杂环支架。设计了一种分子构建块,它结合了 RNA 结合天然产物的特征,包括围绕刚性非平面支架的高密度氢键供体和受体,具有直接的全合成可及性,允许对化学空间进行广泛的控制。1,3-二氮杂环支架的合成是通过前所未有的氰胺诱导的环氧-δ-内酰胺重排实现的。
    DOI:
    10.1021/ol9026914
点击查看最新优质反应信息

文献信息

  • Synthesis of Oxazole Analogs of Streptolidine Lactam
    作者:Kevin D. Rynearson、Sanjay Dutta、Kiet Tran、Sergey M. Dibrov、Thomas Hermann
    DOI:10.1002/ejoc.201300943
    日期:2013.11
    The streptolidine lactam is an amino acid constituent of streptothricin antibiotics, which inhibit protein synthesis by targeting the bacterial ribosome but suffer from toxicity as a result of the basicity of the aminoimidazole scaffold in the natural products. On the basis of the streptolidine structure, we designed and synthesized oxazole analogs with six- and seven-membered lactam rings as building
    链霉内酰胺是链丝菌素抗生素的氨基酸成分,通过靶向细菌核糖体抑制蛋白质合成,但由于天然产物中氨基咪唑支架的碱性而具有毒性。在链霉烷结构的基础上,我们设计并合成了具有六元和七元内酰胺环的恶唑类似物作为 RNA 靶向配体的构建块。这些类似物受益于刚性非平面杂环系统内的氢键供体和受体的密集网络,该系统已减弱碱性。
  • 1,3-Diazepanes of Natural Product-Like Complexity from Cyanamide-Induced Rearrangement of Epoxy-δ-lactams
    作者:Sanjay Dutta、Cody J. Higginson、Bao T. Ho、Kevin D. Rynearson、Sergey M. Dibrov、Thomas Hermann
    DOI:10.1021/ol9026914
    日期:2010.1.15
    A synthetic procedure toward 1,3-diazepane scaffolds of natural product-like complexity was developed for the construction of RNA-directed ligand libraries. A molecular building block was designed that combines the characteristics of RNA-binding natural products, including a high density of hydrogen bond donors and acceptors around a rigid, nonplanar scaffold with straightforward total-synthetic accessibility
    开发了一种合成程序,用于构建 RNA 导向的配体库,以构建具有天然产物样复杂性的 1,3-二氮杂环支架。设计了一种分子构建块,它结合了 RNA 结合天然产物的特征,包括围绕刚性非平面支架的高密度氢键供体和受体,具有直接的全合成可及性,允许对化学空间进行广泛的控制。1,3-二氮杂环支架的合成是通过前所未有的氰胺诱导的环氧-δ-内酰胺重排实现的。
查看更多

同类化合物

7-亚乙基-环戊二烯并(b)环氧乙烷并(c)吡啶六氢衍生物. 4-甲基-3-氧杂-6-氮杂三环[3.2.0.02,4]庚烷-7-酮 3-氧杂-6-氮杂三环[3.2.2.02,4]壬烷(8CI,9CI) 3-氧杂-1-氮杂三环[5.2.0.02,4]壬烷 2-氧杂-6-氮杂三环[4.3.1.01,3]癸烷 (1S,2R,4S,5R)-3-氧杂-6-氮杂三环[3.2.1.02,4]辛烷-7-酮 (5R,7S,8R,8aR)-5-dodecyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one (2S,2R,4S,5R,6S)-(+)-2-{2-[2-[1,3]-dioxolan-2-yl-ethyl]-6-methyl-4,5-epoxy-3,6-dihydro-2H-pyridin-1-yl}-2-phenylethanol (5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one dihydroabikoviromycin (1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1aR,6aS,7R,7aS)-7-(t-butyldimethylsilyloxy)tetrahydro-1aH-oxazolo[3,4-a]oxireno[2,3-d]pyridin-4(2H)-one 11-formyl-(1rN,2tH,4tH,6cN,7tH,9tH)-3,8-dioxa-11-aza-tetracyclo[4.4.1.02,4.07,9]undecane 7-Oxa-2-azabicyclo[4.1.0]heptane (1S,6S)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-Oxa-10-azatricyclo[4.3.1.0~2,4~]decane (3S,5R,6R,7R)-6-hydroxy-4,9-dioxa-1-azatricyclo[5.3.0.03,5]decan-10-one (1RS,2SR,4RS,5SR)-3-oxa-6-azatricyclo[3.2.1.02,4]octan-7-one (1S,6S)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-(methanesulfonyl)-7-oxa-3-azabicyclo[4.1.0]heptane 3α,4α-epoxy-2-piperidone (+)-tedanalactam 5-amino-1,2-anhydro-5-deoxy-D-lyxono-1,4-lactame (1R,5S,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6R)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6S)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-(cyclopropylmethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-ethyl-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methylpropyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methoxyethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,6S)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6S)-7-oxa-2-azabicyclo[4.1.0]heptane (1S,6R)-7-oxa-2-azabicyclo[4.1.0]heptane (1R,6R)-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2S,4R,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2R,4S,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1S,2S,4S,5R)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2S,4R,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1R,6R)-1-methyl-3-propyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2R,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,6S)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane